Neuralink devices are awaiting FDA approval, Mr. Musk said in the interview. He added that the device is working well and can be safely used and removed in monkeys.
In humans, Neuralink is expected to be first used in patients with spinal cord injuries, he said.
“I think we have a chance with Neuralink to restore full-body functionality to someone who has a spinal cord injury,” Mr. Musk said in the interview.
Neuralink is Mr. Musk’s surgical robot company and was founded in 2016. Brain chips have been tested in animals including a monkey and a pig.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
